State Street Corp Charles River Laboratories International, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, State Street Corp holds 2,130,279 shares of CRL stock, worth $400 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,130,279

Previous 2,088,858 1.98%

Holding current value

$400 Million

Previous $432 Million 2.75%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $7.79 Million - $10.2 Million	41,421 Added 1.98%	2,130,279 $420 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $1.08 Million - $1.41 Million	-5,254 Reduced 0.25%	2,088,858 $432 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $6.99 Million - $9.39 Million	34,327 Added 1.67%	2,094,112 $567 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $5.59 Million - $8.12 Million	33,985 Added 1.68%	2,059,785 $487 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $12.7 Million - $14.2 Million	-65,217 Reduced 3.12%	2,025,800 $397 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $6.95 Million - $7.95 Million	37,816 Added 1.84%	2,091,017 $440 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $2.51 Million - $3.4 Million	-13,088 Reduced 0.63%	2,053,201 $414 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $6.93 Million - $8.79 Million	35,148 Added 1.73%	2,066,289 $450 Million
Q3 2022 Nov 15, 2022	BUY	$182.44 - $250.54 $3.48 Million - $4.78 Million	19,084 Added 0.95%	2,031,141 $400 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $2.33 Million - $3.45 Million	-11,420 Reduced 0.56%	2,012,057 $431 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $1.87 Million - $2.65 Million	-7,318 Reduced 0.36%	2,023,477 $575 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $25.8 Million - $32.9 Million	73,315 Added 3.75%	2,030,795 $765 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $21.9 Million - $26.9 Million	58,726 Added 3.09%	1,957,480 $808 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $220 Million - $278 Million	748,211 Added 65.03%	1,898,754 $702 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $2.29 Million - $2.75 Million	-9,170 Reduced 0.79%	1,150,543 $333 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $5.45 Million - $6.2 Million	24,537 Added 2.16%	1,159,713 $290 Million
Q3 2020 Nov 10, 2020	SELL	$175.56 - $226.45 $10.8 Million - $13.9 Million	-61,480 Reduced 5.14%	1,135,176 $257 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $5.31 Million - $8.48 Million	44,689 Added 3.88%	1,196,656 $209 Million
Q1 2020 May 11, 2020	BUY	$98.9 - $178.34 $114 Million - $205 Million	1,151,967 New	1,151,967 $145 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Charles River Laboratories International, Inc. Transaction History